Antithymocyte Globulin (atg) - Infectious Diseases

Relevant Publications

Outcomes of Older Primary Kidney Transplant Recipients by Induction Agent and High-risk Viral Discordance Status in the United States.

Issue Release: 2024

Comparison of hematopoietic stem cell transplantation and repeated intensified immunosuppressive therapy as second-line treatment for relapsed/refractory severe aplastic anemia.

Issue Release: 2024

Progress in medical therapy in aplastic anemia: why it took so long?

Issue Release: 2024

The Effect of Induction Therapy on Antibody-Mediated Rejection in Kidney Transplantation: A Network Meta-Analysis Using Recent Data.

Issue Release: 2024

Predictive value of thyroid function in severe aplastic anemia patients treated with immunosuppressive therapy.

Issue Release: 2024

Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation.

Issue Release: 2024

Modified G-CSF/ATG-Based Haploidentical Transplantation Protocol in Pediatric Primary Hemophagocytic Lymphohistiocytosis: A Long-Term Follow-Up Single-Center Experience.

Issue Release: 2024

Analysis of risk factors and prognosis of diarrhea after renal transplantation.

Issue Release: 2024

Activity and safety of eltrombopag in combination with cyclosporin A as first‑line treatment of adults with severe aplastic anaemia (SOAR): a phase 2, single-arm study.

Issue Release: 2024

High-dose individualized antithymocyte globulin with therapeutic drug monitoring in high-risk cord blood transplant.

Issue Release: 2024

The Impact of Induction Therapy on the Risk of Post-Transplant Lymphoproliferative Disorder in Adult Kidney Transplant Recipients with Donor-Recipient Serological Epstein-Barr Virus Mismatch.

Issue Release: 2024

Efficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-naïve and relapsed/refractory severe aplastic anaemia: protocol for the DIAAMOND-Ava-FIRST and DIAAMOND-Ava-NEXT Bayesian Optimal Phase II trials.

Issue Release: 2024

Secondary solid malignancies and precancerous lesions after allogeneic hematopoietic stem cell transplantation using non-total body irradiation-based conditioning in acute myeloid leukemia.

Issue Release: 2024

Moving from insulin substitution to the treatment of the underlying autoimmune disease in type 1 diabetes.

Issue Release: 2024

Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence.

Issue Release: 2024

Cell-mediated Immunity to Guide Primary Prophylaxis for CMV Infection in Organ Transplant Recipients: A Multicenter Single-arm Prospective Study.

Issue Release: 2024

The prophylactic application of low-dose rabbit antithymocyte globulin in matched siblings HSCT with high-risk factors for graft-versus-host disease.

Issue Release: 2024

Clinical outcomes of three haploidentical transplantation protocols for hematologic malignancies based on data from the Chinese Bone Marrow Transplantation Registry Group.

Issue Release: 2024

Long-Term Outcomes of Induction Immunosuppression for Kidney Transplant Recipients With HIV Who Have Average Immunologic Risk: An Inverse Probability Treatment Weighting Analysis.

Issue Release: 2024

What is the global impact of Flaviviridae infections?

What is Infectious Disease Surveillance?

How Are Respiratory Symptoms Diagnosed?

What Do the Results Mean?

What is Mycobacterium Tuberculosis?

How Can We Promote Condom Use?

How Can Measles be Prevented?

Can Infectious Diseases Be Prevented?

What is Glycolysis?

How Can Individuals Contribute to One Health?

Antithymocyte Globulin (atg) - Infectious Diseases

Relevant Publications

Partnered Content Networks

Relevant Topics